Skip to main content

18F-FDG PET/CT: Normal Variants, Artefacts and Pitfalls in Lymphoma

  • Chapter
  • First Online:
PET/CT in Hodgkin’s Lymphoma

Part of the book series: Clinicians’ Guides to Radionuclide Hybrid Imaging ((PET/CT))

  • 709 Accesses

Abstract

FDG PET/CT has become a standard imaging in the staging and response assessment of FDG-avid lymphoma. Accurate interpretation of scan findings is crucial in guiding most effective treatment. It is important to recognise normal variants and potential artefacts and pitfalls in lymphoma FDG PET/CT to achieve optimal results. These potential limitations include the issues applicable to FDG PET/CT in general as well as situations more relevant to lymphoma and its locations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Further Reading

  1. Barrington SF, Mikhaeel NG, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International conference on malignant lymphomas Imaging Working Group. J Clin Oncol. 2014;32(27):3048–58.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Cheson BC, et al. Recommendations for Initial evaluation, staging and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–68.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Bolellard R, et al. FDG PET/CT: EANM procedural guidelines for tumour imaging version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54.

    Article  Google Scholar 

  4. Peas FM, et al. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics. 2010;30:269–91.

    Article  Google Scholar 

  5. Barrington SF, Mikhaeel NG. When should FDG-PET be used in the modern management of lymphoma? Br J Haematol. 2014;164:315–28.

    Article  PubMed  Google Scholar 

  6. Corrigan AJG, et al. Pitfalls and artifacts in the use of PET/CT in oncology imaging. Semin Nucl Med. 2015;45:481–99.

    Article  PubMed  Google Scholar 

  7. Karantanis D, et al. 18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients. Nucl Med Commun. 2007;28:834–41.

    Article  PubMed  Google Scholar 

  8. Hoang-Xuan K, Bessell E, et al. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol. 2015;16:e322–32.

    Article  PubMed  Google Scholar 

  9. Tsamita CS. Clinical significance of axillary findings in patients with lymphoma during follow up with 18F-fluorodeoxyglucose PET. Nucl Med Commun. 2008;29:705–10.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sai Han .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Han, S. (2017). 18F-FDG PET/CT: Normal Variants, Artefacts and Pitfalls in Lymphoma. In: Kayani, I. (eds) PET/CT in Hodgkin’s Lymphoma. Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-319-57225-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-57225-3_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-57224-6

  • Online ISBN: 978-3-319-57225-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics